Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Joseph Bailes

McKinney, TX Medical Doctor

CMS profile 1287588

7901 Trading Post Dr, McKinney, TX 75070

Open in the dashboard

General payments

$1,857,227

159 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$2,432,729

7 holdings reported · through program year 2025

Through program year 2025, Joseph Bailes of McKinney, TX is reported in the CMS Open Payments database as having received $1,857,227 across 159 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $2,432,729 across 7 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

By program year

14 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $64,000 3
2024 General $56,000 5
2023 General $951,464 13
2022 General $105,194 30
2021 General $154,611 19
2020 General $251,241 38
2019 General $274,717 51
2025 Ownership $488,673 1
2024 Ownership $424,819 1
2023 Ownership $292,025 1
2022 Ownership $433,126 1
2021 Ownership $391,309 1
2020 Ownership $283,414 1
2019 Ownership $119,363 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Joseph Bailes
  • Texas median
  • Middle half of Texas
  • National median

In program year 2025, general payments to Joseph Bailes were reported at $64,000. Among 86,592 Texas profiles paid that year, the median was $188 and the middle half received between $55 and $669.

Show as a table
Year Joseph Bailes Texas median Middle half National median
2019 $274,717 $191 $56–$744 $163
2020 $251,241 $125 $38–$452 $114
2021 $154,611 $150 $43–$543 $132
2022 $105,194 $169 $50–$606 $149
2023 $951,464 $183 $53–$639 $160
2024 $56,000 $188 $55–$666 $164
2025 $64,000 $188 $55–$669 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. TerSera Therapeutics LLC $943,019 35 payments
  2. Taiho Oncology, Inc. $267,100 27 payments
  3. Rigel Pharmaceuticals, Inc. $232,449 33 payments
  4. Jazz Pharmaceuticals Inc. $225,452 31 payments
  5. ChromaCode, Inc $92,000 1 payment
  6. Cardinal Health 110, LLC $57,019 13 payments
  7. Coherus Biosciences Inc. $20,000 7 payments
  8. Genzyme Corporation $13,313 10 payments
  9. Kite Pharma, Inc. $5,000 1 payment
  10. Advanced Accelerator Applications $1,875 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $1,074,810 119 payments
  2. Acquisitions $769,713 1 payment
  3. Travel and Lodging $11,888 24 payments
  4. Food and Beverage $816 15 payments
Products named General payments · program years 2019–2025
  1. Tavalisse $232,449 33 payments
  2. Lonsurf $190,100 22 payments
  3. Rezlidhia $168,041 11 payments
  4. ZEPZELCA $93,000 15 payments
  5. Gavreto $64,000 3 payments
  6. VYXEOS $56,254 7 payments
  7. Udenyca $20,000 7 payments
  8. CD38 $11,395 9 payments
  9. ZOLADEX $6,948 2 payments
  10. Yescarta $5,000 1 payment
  11. Other $6,500 3 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

159 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record